FDA Inspection 1251947 — Savita Rangarajan, MD, MBBS, FRCPath

Savita Rangarajan, MD, MBBS, FRCPath — FEI 3030980582

The FDA completed an inspection of Savita Rangarajan, MD, MBBS, FRCPath on Sep 27, 2024 in Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.